Faces Of Digital Health

The promise of voice is great: doctors speak to their patients, while their words get correctly transcribed, interpreted and recorded in a structured way in a clinical system. No more long hours spent on typing clinical notes on the computer. While this may seem futuristic, it’s actually already in use in some places. At HLTH in November, I spoke with Punit Singh Sonu, CEO of Suki, which provides doctors with an AI-powered voice assistant for healthcare designed to save doctors time and energy. We discussed how Suki works, how it translates text to structured data, and how clinically risky is to rely on AI to interpret medication names which can very quickly sound alike correctly.  The biggest issue, says Punit Singh Sonu, is not specialty phrases, it’s regular English. “The problem typically happens not in medical terminology. It happens in regular English. I'll give you a very funny example. The doctor would just say “bilateral knee,” and it would actually understand it as “beyonce knowles”. Regular English

ChatGPT has been entertaining and amazing the world in the last month, and there’s no shortage of ideas and new inspiration about what AI could do for healthcare. In a short series of three episodes, we will touch upon this topic from three angles: will first take a look at the state of symptom checkers and their accuracy today, the development and state of voice tech and natural language processing for structuring data, and end with a comment on ChatGPT, chatbots and Google’s recently released paper on MultiMedQA, a benchmark combining six existing open question answering datasets spanning professional medical exams, research, and consumer queries; and HealthSearchQA, a new free-response dataset of medical questions searched online.  Today you’ll hear from a discussion with Jeff Cutler - Chief Commercial Officer of Ada Health, whom I spoke with at HLTH.  Ada is the world's most popular symptom assessment app, with 10 million users and 25 million completed assessments. Every three seconds, someone turns

 We tend to be very good at overestimating what can happen in a year and underestimating what can happen in a decade. At the last mHealth Israel Conference in Tel Aviv,  Mark Coticchia, who is the Innovation, Technology Commercialization, and Venture Development Leader at Baptist Health Innovations, shared his prediction about healthcare systems and healthcare delivery in the US in 2033. Transcript: https://www.facesofdigitalhealth.com/blog/mark-coticchia-baptist-health Leave a rating or review: www.lovethepodcast.com/facesofdigitalhealth Monthly newsletter: https://fodh.substack.com/

This episode is the second about the evolution of mental health companies. In the previous episode, you could listen to Katie Di Perna Cook - SVP of Partnerships at Headspace Health, and today, we’re continuing the topic with Luke Hejl, CEO of TimelyMD, the leading virtual health and well-being solution for college students, CCO of Iris Telehealth, a leading provider of telepsychiatry services for health systems and community health centers across the U.S.. Luke and Michael talked about the state of mental health in the younger population and how the two companies look at digital innovation and digital therapeutics in the mental health space. 9 out of 10 students said they’re dealing with anxiety, said Luke Hejl, and as mentioned by Michael Maus, 1 out of 4 people that need mental health services actually look for them. So three out of four people needing them do not get help.   Iris Telehealth: https://iristelehealth.com/ TimelyMD: https://timely.md/ Subscribe to the newsletter: https://fodh.substack.com/

The pandemic has significantly increased the need for mental healthcare and destigmatized discussing well-being and mental health issues in everyday conversation. Unfortunately, the number of quality providers of mental health services is still much lower than the demand, and the number of people that are seeking help is rising.  At HLTH or Health conference, which took place in November in Las Vegas, I spoke with representatives of 3 mental health-focused companies based in the US. TimelyMD is the ninth-fastest growing health services company in the US, according to Inc., and focuses on the mental health of students,, Iris Telehealth is a leading provider of telepsychiatry services for health systems and community health centers across the U.S. and Headspace Health -the largest digital mental health provider in the world - it is reaching 100 million people in 190 countries across the world.  In this episode, we’ll dive into a discussion with Katie DiPerna Cook - SVP of Partnerships - Headspace Health. The co

If someone told you to get an eye exam, would you associate that with a virtual reality headset? It might be where ophthalmology diagnostics will end up in the near future. Compared to the existing diagnostics tools, a VR approach is much more portable and hence accessible. The Swiss company PeriVision is using AI and VR to enable more efficient workflows and deeper clinical insights to manage eye diseases better. I spoke with the co-founder and CEO of Perivision, Patrick Kessel. Prior to joining PeriVision, Patrick advised Medtech, biopharma, and insurance clients on business development, go-to-market strategy, digitization, and operations optimization at the Boston Consulting Group (BCG). We discussed how VR and AI help in eye care, what the competition is in the field, and how did the company evolve. Perivison won EIT Health’s Wild Card program in 2021 and received 1.5 million euros for its further development. Patrick shared his reflection on the wild card program and which startups the program is most su

Last year, one of the key buzzwords in healthcare was virtual care; in 2020 it was probably telemedicine. In 2019 it was AI, in 2017 and 2018, it was blockchain in interoperability. There are many others of course, and many of these terms are still popular today. It seems, though, that the one term that got pushed most in the background, is blockchain. And that’s a good thing, says John Bass, Founder & CEO of Hashed Industries (dba Hashed Health), a healthcare-focused venture studio. John is an internationally recognized author and speaker on value-based care, blockchain, and decentralized healthcare technology. He is the co-author of the HIMSS-published book “Blockchain in Healthcare: Innovations that Empower Patients, Connect Professionals and Improve Care." This short discussion was recorded at HLTH 2022 conference in Las Vegas. John talks about: where is blockchain in 2022, what can we expect in the future, how it relate to web3, and what could NFT - nonfungible tokens do for healthcare. Transcript: www.

The European Health Data Space is supposed to be implemented in a bit more than two years, by 2025. Two goals are at the forefront: to create the infrastructure for a European health data pool for researchers and innovators, and secondly, to enable patients to pick up their medications outside their home country and give doctors across Europe access to their patient information, if in need of medical care while abroad in Europe. On 18 November, EIT Health Germany-Switzerland and EIT Health Spain organized a joint symposium titled Right to privacy vs. duty to protect lives: Health Data Management in Focus. Speakers discussed patients’ perspectives on Health Data use and the EHDS, balancing health data privacy and AI development, ongoing approaches for data solutions, and more. I managed to speak with Nick Schneider, Head of division 511 on new technologies and data use at the Germany Federal Ministry of Health to discuss:  Where is EHDS at the moment Will it be implemented by 2025 What are still the biggest

Nurses play a key role in patient care, but their contribution to patient outcomes is often undervalued and underappreciated. It took a pandemic to create a major shift in their job opportunities and power to negotiate. Many nurses left the profession entirely, others switched to better-paid travel or agency jobs. The pandemic is settling down so the question debated in today’s episode, is what is the position the nurses are in today? You will hear from: Rebecca Love, Thought Leader on Nurse Innovation & Entrepreneurship, experienced nurse executive and entrepreneur, and Chief Clinical Officer of IntelyCare, Alice Benjamin, nurse, author, and health advocate is affectionately known as America's favorite nurse. Rebecca and Alice talked about the position of nurses, healthcare technologies that are not designed to make the work of nurses easier, recent criminal cases against nurses in the US, and what needs to change so that being a nurse will be an attractive job opportunity. Let’s dive in, and if you wil

Between 13 and 16 November, HLTH, the largest digital health conference with over 9000 attendees, took place in Las Vegas. Over 400 speakers discussed the current trends and challenges in the industry. This short episode recaps some of the discussed topics - investment trends, holistic healthcare: food as medicine, digital therapeutics, mental health trends, telemedicine decline, patient experience as a determinant of care, health disparities and more. Speakers: Smriti Kirubanandan, Healthcare Strategist and Board Member of The World Food Bank,  Lyndsey (McKay) Harper, Ob/Gyn, Founder/CEO of Rosy  Aline Noziet, Digital Health Connector from Barcelona, Spain Hagai Heshes, Head of Product Marketing at TytoCare  Erica Olenski Johansen, Caregiver and Patient Advocate  Julien de Sallabery, CEO of Galen Growth Read the transcript in the newsletter: https://fodh.substack.com/ Leave a rating or a review: lovethepodcast.com/facesofdigitalhealth Official website: www.facesofdigitalhealth.com *** Past episodes

Finn Partners and Galen growth Asia partnered for a global overview of the digital health investment landscape. More than 200M data points from more than 12,000 digital health ventures worldwide were taken into account when assessing the state of the industry.   In this short discussion, the CEO of Galen Growth Asia Julien de Salaberry, explained the key findings from the report, the state of digital health in China and expectations from next year. Investment trends globally: - In the first 9 months of 2022, venture funding across the globe declined by 35% YOY ($25 B compared to $39.23B over the same quarters in 2021) - 60% of the total volume comes from North America, the Middle East came in second in Q2, and Europe did NOT see a quarter-on-quarter decrease in venture funding seen in North America. - Top investment categories: oncology (though the funding shrinked by 30%) and mental health Predictions for 2023:  - Investors are moving from Fear of Missing Out (FOMO) to Fear of Looking Foolish (FOLF) - Ventu

For new ideas and solutions to reach the market, startup founders need to find the right partners that are willing to listen to them and take their ideas one step further. Established in 2015, the Health Innovation Hub & Holding provides years of expert ​knowledge in innovation pathways, paving the way for better healthcare and a sustainable healthcare industry. The European organization better known under the name of Innovation in health has many programs in its portfolio. In this episode Hannes Toivanen, Lead, Global Digital Ecosystem Engagement at Takeda and Jesus Jeronimo Director of New Digital Services & Products at Sanitas + BUPA ELA. Jesus and Hannes talked about how pharma, insurance companies and healthcare providers work with startups, what makes a successful partnership, and why their organizations took part in the Innovation in health programs Start-ups Meet Pharma (Takeda) and start-ups Meet Healthcare Providers (Sanitas + BUPA ELA). More about Innovation in health: https://innovationinhealth.eu

In the previous episode, you had a chance to listen to  Dr Phil Koczan, GP in North East London and the Chief Clinical Safety Officer for London, Dr Katherine Buxton, Consultant in Palliative Care Medicine for Imperial College Healthcare NHS Trust and Clinical Director, Palliative and End of Life Care Strategic Clinical Network for London talk about the recently introduced digitized urgent care planning across London.  OneLondon is a project that supports a vision of joined-up health and care. It is a pan-London collaboration between leaders from the 5 Integrated Care Systems in the capital.  London’s healthcare system is complex. It covers a population of 10 million people and is connecting 35 NHS Trusts and 1385 GP practices.  In this episode, Gary McAllister, Chief Technology Officer of OneLondon explains how is London approaching the digital transformation of healthcare in London, how complex is the IT infrastructure at the moment, and how the core team of OneLondon works with vendors to try to connect di

Too often, patients need to repeat their medical history when in contact with different healthcare providers. Consequently, clinicians need more time to make decisions than necessary because they can’t access patient data. London managed to digitize urgent care plans and make them available across 40 NHS Trusts and 1400 GP offices.  This episode presents the Urgent Care Plan Programme, aiming at giving clinicians easy access to patients’ desires about their care, as defined in their care plan. Patients can fill out an urgent care plan at various points in their patient journey. The problem so far has been that accessing these plans by different providers was often difficult. Now the situation is improved with an introduction of a regional platform that stores urgent care plans and enables different care teams to access them when needed.  Urgent Care Plan Programme is a part of OneLondon Portfolio. OneLondon is a project that supports a vision of joined-up health and care. It is a pan-London collaboration betw

Medical progress is driven by research, and good research requires good data. The largest single-site cancer center in Europe and the biggest chemotherapy center in the UK - The Christie NHS Foundation Trust runs 650 clinical trials at any given time. They recently went live with a new electronic Patient Reported Outcome Measures (ePROMs) service helping to connect patients with the hospital trust through their cancer journey. As explained by Phil Bottomley, EHR Strategic Lead at The Christie NHS Foundation Trust, the digitization of ePROMs is only the beginning of the digitalization process of over 600 clinical forms used in the hospital. The hospital’s digital transformation strategy is based on a data-first approach, ensuring that the used data models enable the creation of a longitudinal record. They chose openEHR specification - a product and vendor-independent specification, striving to make data independent of any software provider. Subscribe to the newsletter to receive a recap of the whole cancer se

We are in the middle of a series of discussions related to cancer care, treatment improvements, data management in oncology, and the promise of AI to find the right treatment for the right patient in the fastest possible manner. As mentioned by Xose M. Fernandez, a genomicist and former chief data officer at Institute Curie, a faster diagnosis could lead to less aggressive treatment and better patient outcomes.  We covered many perspectives so far: accessibility and cost of cancer treatments in the US and Canada in the first episode, genetics, data management, and the science of cancer; we talked about AI treatments and challenges in designing clinical trials in personalized medicine. This episode focuses on the consequences cancer diagnosis has after patients are cured. Many cancer survivors in long-term remission face restricted access to financial services because of their medical history. Some EU countries have already implemented the right to be forgotten - a right for patients not to disclose their medi

This is the 3rd episode in the Cancer Series. In this episode, you’ll hear a bit about precision medicine in oncology, drug repurposing and the increasing challenges precision medicine poses for clinical trials. I spoke with Tuvik Beker, CEO of Pangea Biomed, an Israeli-based company tackling oncology drug development and treatment recommendation by not only looking at the single mutations in tumor cells, which the Pharmaceutical industry has already found targeted therapies for. Cancer treatments are evolving very rapidly, but precision and targeted therapies are still only effective in roughly 10% of cancer patients. Pangea Biomed tries to understand broader gene activation patterns inside tumor cells and recommends a therapy that would help exploit cancer cells’ defense mechanisms.  As explained in simplified terms by Tuvik Beker. Cancer Series Ep. 1: Access to Care, Financial Toxicity and Healthcare IT in Oncology Speaker: David J. Stewart, MD, FRCPC, Professor of Medicine in the Division of Medical Onc

This is the second episode in a special series about cancer, cancer care, accessibility and technologies related to cancer care. The first episode focused on the current state of cancer care with a speaker from Canada - David J. Stewart, MD, FRCPC, Professor of Medicine in the Division of Medical Oncology at the University of Ottawa and The Ottawa Hospital. David explained the current state of cancer care, IT in oncology and financial toxicity of a cancer diagnosis for patients.  This, second episode, dives into genomics, the role of AI, and data science in oncology. Speaker: Xose M. Fernandez, genomicist and up until recently the Chief Data Officer at Institut Curie in France, one of the leading medical, biological, and biophysical research centers in the world.   SUBSCRIBE TO THE MONTHLY NEWSLETTER: https://fodh.substack.com/ www.facesofdigitalhealth.com Leave a rating or a review: lovethepodcast.com/facesofdigitalhealth Thank you! :)

There were an estimated 18.1 million cancer cases around the world in 2020, according to the World Cancer Research Fund International. According to the Comparator Report on Cancer in Europe 2020, the absolute number of people diagnosed with cancer rose around 50% in Europe over the past 20 years. However, the number of deaths only increased by 20%. The numbers show we’re making great strides in survival and treatments and early screenings. But because of the aging population, cancer care and prevention are rising global public health concerns.  In the next few episodes, we’ll talk about cancer, cancer care, and technology, the role of data and IT for improved care and research, AI in the search for new therapies, but also about cancer survivorship: what happens to patients after they are cancer free, but unfortunately far from back to the life they had before cancer.  Speaker in this episode is David J. Stewart, MD, FRCPC, Professor of Medicine in the Division of Medical Oncology at the University of Ottawa a

This episode explores the role of at-home diagnostic testing in managing and preventing sexually transmitted diseases. More than 1 million sexually transmitted infections (STIs), which include syphilis, gonorrhea, chlamydia, HIV hepatitis, and other infections, are acquired every day worldwide. The majority of STIs are asymptomatic early detection that much more important to prevent the spread of these diseases. According to WHO, globally, 38.4 million people were living with HIV at the end of 2021. Science has advanced immensively to help treat and manage HIV. For over a decade, populations at risk can take preventative pills, which prevent HIV infections by over 99%. Unfortunately, access to this prophylaxis shouldn’t be taken for granted. In the US, prevention is supposed to be covered by insurance under the Affordable Care Act. However, in September, a district court ruling in Texax potentially endangered this access. A Christian-owned company argued against the Affordable Care Act’s requirement that ins